GGrantIndex
← Leaderboards

Paul Tempst

Sloan-Kettering Institute For Cancer Res

$13,376,215
Attributed
$14,937,539
Total exposure
8
Grants
5
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2M · FY200521
$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21

Funding mix

By agency

NIH$14,937,539 · 8

By mechanism

U24$7,985,219 · 1
R01$3,122,649 · 1
P30$2,295,208 · 3
R21$907,684 · 2
R33$626,779 · 1

Top collaborators

Most similar at Sloan-Kettering Institute For Cancer Res

Same institution · by research overlap

Others in their field

Top investigators on “Base

Research focus

BaseSamplingPatternProteomicsProteinsSerumMalignant NeoplasmsPerformanceLabelDetectionPeptide HydrolasesProteomeEnzymesMeasurementPeptidesBiological MarkersBiologicalMalignant Breast NeoplasmOperative Surgical ProceduresCancer TypeMemorial Sloan-Kettering Cancer CenterMonitorDiagnosticMass Spectrum Analysis

Grant awards (29)

Protein and proteolytic activity biomarkers of early stage pancreatic cancer$623,472
R01 · FY2021 · CA · contact PI
Protein and proteolytic activity biomarkers of early stage pancreatic cancer$623,472
R01 · FY2020 · CA · contact PI
Protein and proteolytic activity biomarkers of early stage pancreatic cancer$614,311
R01 · FY2019 · CA · contact PI
Protein and proteolytic activity biomarkers of early stage pancreatic cancer$618,868
R01 · FY2018 · CA · contact PI
Protein and proteolytic activity biomarkers of early stage pancreatic cancer$642,526
R01 · FY2017 · CA · contact PI
Immobilized protease activity tests for developing functional cancer biomarkers.$229,550
R21 · FY2016 · CA · contact PI
Immobilized protease activity tests for developing functional cancer biomarkers.$267,808
R21 · FY2015 · CA · contact PI
Immobilized protease activity tests for developing functional cancer biomarkers.$266,362
R21 · FY2014 · CA · contact PI
MICROCHEMISTRY and PROTEOMICS$54,577
P30 · FY2011 · CA · contact PI
Assessment of serum peptide profiling to detect cancer-specific patterns$1,418,018
U24 · FY2010 · CA · contact PI
MICROCHEMISTRY and PROTEOMICS$397,423
P30 · FY2010 · CA · contact PI
Assessment of serum peptide profiling to detect cancer-specific patterns$1,417,183
U24 · FY2009 · CA · contact PI
Assessment of serum peptide profiling to detect cancer-specific patterns$349,355
U24 · FY2009 · CA · contact PI
MICROCHEMISTRY and PROTEOMICS$202,351
P30 · FY2009 · CA · contact PI
Assessment of serum peptide profiling to detect cancer-specific patterns$1,543,596
U24 · FY2008 · CA · contact PI
MICROCHEMISTRY and PROTEOMICS$202,021
P30 · FY2008 · CA · contact PI
Assessment of serum peptide profiling to detect cancer-specific patterns$1,613,081
U24 · FY2007 · CA · contact PI
Peptide Profiling Techniques to Detect Thyroid Carcinoma$307,752
R33 · FY2007 · CA · contact PI
Assessment of serum peptide profiling to detect cancer-specific patterns$1,643,986
U24 · FY2006 · CA · contact PI
Peptide Profiling Techniques to Detect Thyroid Carcinoma$319,027
R33 · FY2006 · CA · contact PI
Peptide Profiling Techniques to Detect Thyroid Carcinoma$143,964
R21 · FY2005 · CA
CORE--MICROCHEMISTRY$157,506
P30 · FY2002 · CA
CORE--DEVELOPMENTAL FUNDS$157,506
P30 · FY2002 · CA
CORE--DEVELOPMENTAL FUNDS$157,506
P30 · FY2001 · CA
CORE--MICROCHEMISTRY$157,506
P30 · FY2001 · CA
CORE--MICROCHEMISTRY$246,900
P30 · FY2000 · CA
CORE--DEVELOPMENTAL FUNDS$246,900
P30 · FY2000 · CA
CORE--MICROCHEMISTRY$157,506
P30 · FY2000 · CA
CORE--DEVELOPMENTAL FUNDS$157,506
P30 · FY2000 · CA